SCHEMBL2233228

SCHEMBL2233228

O=C(O)c1n[nH]cc1NCc1c(F)cccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD38 P28907 5/20 0.41
CDC7 O00311 1/20 0.39
NTRK1 P04629 1/20 0.39
PLK1 P53350 1/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPK14 Q16539 2/20 0.36
LCK P06239 1/20 0.36
BTK Q06187 1/20 0.36
ROCK2 O75116 2/20 0.36
ROCK1 Q13464 2/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PTGER2 P43116 1/20 0.35
CYP3A4 P08684 1/20 0.34
KCNH2 Q12809 1/20 0.34
NPC1 O15118 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC8 Q9BY41 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL955039 0.76 MEN1 (0.49) NTRK1PLK1MEN1KMT2ALCK
SCHEMBL8768550 0.74 HCAR2 (0.32) KDM4E
SCHEMBL8219739 0.73 MEN1 (0.43) MEN1KMT2AMAPK14ROCK2ROCK1
SCHEMBL2804529 0.72 L3MBTL1 (0.52) MEN1KMT2AKDM4EALDH1A1TDP1
SCHEMBL1645592 0.71 JAK2 (0.52) MEN1KMT2ANPC1
SCHEMBL12992949 0.70 MEN1 (0.40) NTRK1PLK1MEN1KMT2AMAPK14
SCHEMBL3942467 0.69 CDK2 (0.48) NTRK1PLK1MEN1KMT2ALCK
SCHEMBL10917448 0.68 FABP4 (0.46) MEN1KMT2AMAPK14KDM4EALDH1A1
SCHEMBL27696959 0.68 HDAC3 (0.40) KDM4EALDH1A1NPC1HDAC1HDAC8
SCHEMBL2801400 0.68 L3MBTL1 (0.53) MEN1KMT2AALDH1A1TDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651612-B9 3,4-DISUBSTITUTED 1H-PYRAZOLE COMPOUNDS AND THEIR USE AS CYCLIN DEPENDENT KINASES (CDK) AND GLYCOGEN SYNTHASE KINASE-3 (GSK-3) MODULATORS ASTEX THERAPEUTICS LTD (GB) 2012-09-05 EP disclosed
US-7977477-B2 Benzimidazole derivatives and their use as protein kinase inhibitors ASTEX THERAPEUTICS, LIMITED (GB) 2011-07-12 US disclosed